Child and caregiver issues in the treatment of attention deficit–hyperactivity disorder: education, adherence and treatment choice

Author:

Ferrin Maite1,Taylor Eric

Affiliation:

1. Department of Child & Adolescent Psychiatry (SGDP P046), King’s College London Institute of Psychiatry, De Crespigny Park, London SE5 8AZ, UK

Abstract

There is much more to successful drug treatment than writing a prescription. In this article, we describe some of the ‘holistic’ aspects of the pharmacological treatment of attention deficit–hyperactivity disorder, with an emphasis on helping families to decide between psychological and pharmacological treatment and on the process of psychoeducation. Detailed accounts of drug and behavioral treatment in various circumstances are available elsewhere; however, the value and process of psychoeducation is sometimes underestimated or referred to in a cursory statement of the need for a good doctor–patient relationship. There has been little in the way of controlled trials, so no meta-analysis is attempted. Where possible (e.g., in reviewing the effects of psychological therapy and prediction of drug response), PubMed/Medline was searched for systematic reviews and randomized trials, but this article’s conclusions should be taken as personal. These subjective views are based chiefly on experience in clinical practice, participation in focus groups with young people and their families and work with support groups.

Publisher

Future Medicine Ltd

Subject

Neurology (clinical),Neurology

Reference55 articles.

1. Developing ADHD

2. European clinical guidelines for hyperkinetic disorder ? first upgrade

3. Long-acting medications for the hyperkinetic disorders

4. National Institute for Health and Clinical Excellence (NICE):Attention Deficit Hyperactivity Disorder. Diagnosis and Management of ADHD in Children, Young People and Adults. The British Psychological Society and The Royal College of Psychiatrists, UK (2009).

5. Evidence-Based Psychosocial Treatments for Attention-Deficit/Hyperactivity Disorder

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3